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Abstract
The saliva of haematophagous arthropods contains an array of anti-haemostatic, anti-inflammatory and
immunomodulatory molecules that contribute to the success of the blood meal. The saliva of haematophagous
arthropods is also involved in the transmission and the establishment of pathogens in the host and in allergic
responses. This survey provides a comprehensive overview of the pharmacological activity and immunogenic
properties of the main salivary proteins characterised in various haematophagous arthropod species. The potential
biological and epidemiological applications of these immunogenic salivary molecules will be discussed with an
emphasis on their use as biomarkers of exposure to haematophagous arthropod bites or vaccine candidates that
are liable to improve host protection against vector-borne diseases.
Review
During the course of evolution, haematophagy has
arisen many times in disparate arthropod taxa. Between
the taxa, this feeding habit has evolved independently
over several million years [1,2] leading to morphophy-
siological differences among haematophagous arthro-
pods. At the molecular level, this is reflected by the
existence of a variety of pharmacologically active mole-
cules in arthropod saliva used to face the constraints of
vertebrate host haemostasis, inflammation and adaptive
immunity [3-5].
The saliva of haematophagous arthropods is also
responsible for causing allergic responses in human
hosts, which are manifested by cutaneous pruritic
wheal-and-flare reactions at the bite site [6,7]. Thus, a
high density of haematophagous arthropods can directly
affect human populations worldwide due to their pre-
sence and physical nuisance [8,9]. Beside this direct
effect, arthropods can also indirectly affect human
health by transmitting pathogens. Indeed, many viral,
bacterial, and eukaryotic pathogens have found haema-
tophagous arthropods ideal vectors to accomplish trans-
mission among vertebrates. Usually, a long-lasting co-
speciation has led to specific associations between
pathogens and vectors [2]. Hence, pathogens often
depend on few related species of vectors for transmis-
sion (Table 1). Some of these pathogens have even
taken advantage of the immunomodulatory properties of
haematophagous salivary proteins in order to enhance
their infectivity in the vertebrate host [10,11].
Arthropod-borne diseases are a major health problem
worldwide. They cause serious impacts on the economy
and survival of human populations living mainly in tro-
pical and sub-tropical countries [12-14]. To a lesser
extent, human populations in developed countries are
also exposed to a variety of vector-borne pathogens
[15-17]. Pathogen vaccine and prophylactic drug
research have so far produced little to protect indivi-
duals from many arthropod-borne diseases. Currently,
vaccines are only available for the yellow fever virus
[18], the Japanese encephalitis virus [19], the Rift valley
fever virus [20] and the tick-borne encephalitis virus
[21]. Protection against Plasmodium, the malaria para-
sites, still relies on the use of prophylactic drugs and is
hampered by the escalation of drug-resistance [22].
Thus, the primary mechanism to protect individuals
from vector-borne diseases is the prevention of bites
from infected arthropods. This can be achieved by a
combination of personal protective measures and vector
control strategies adapted to vector behaviour [23-26].
These methods have been historically successful in
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of some vector-borne diseases. Currently, the effective-
ness of anti-vectorial measures and the evaluation of the
transmission of arthropod-borne diseases are deter-
mined by laboratory bioassay tests [32-35], by measuring
the incidence, morbidity or mortality of vector-borne
diseases in controlled clinical trials in the field [36,37]
or by entomological methods [38,39]. Concerning mos-
quito-borne diseases, the entomological reference
method to measure vector density is by catching landing
mosquitoes on humans, which provides a good estimate
of the average number of bites per person per day
received from one particular vector species [40]. How-
ever, in terms of execution and supervision, this method
is very laborious and dependent on the skills of the col-
lector. In addition, the deliberate exposure of human
volunteers to vectors has raised some ethical issues
against this technique. As the human bite rate was
shown to vary within small geographic areas [41,42], the
results of local catches cannot be extrapolated to larger
areas. Additionally, results from the human landing
catch performed by adults can be difficult to extrapolate
to children. Alternative entomological methods exist to
capture medically important haematophagous arthro-
pods, such as carbon dioxide dry ice traps, light traps
and odour baited traps (to collect flying dipterans) [43]
or the drag-flag method (to collect ticks) [44]. However,
these tools do not differentiate anthropophilic from zoo-
philic arthropods and cannot precisely assess the contact
between haematophagous arthropods and host. Hence,
the development of new indicators and methods to eval-
uate the effectiveness of anti-vectorial strategies at the
individual level is necessary.
A common feature shared among arthropod vectors is
their habit of feeding on blood involving the injection of
saliva into the host’ss k i n .O n ec o n s e q u e n c eo ft h e
injection of salivary proteins is the eliciting of host anti-
body responses against these pharmacologically active
components [45-51]. Such observations suggest that
these antigenic components could potentially be used as
immunological tools to evaluate individual exposure to
arthropod bites.
This present survey is particularly concerned with the
current knowledge of antibody responses to the salivary
proteins of haematophagous arthropods. Immunogenic
salivary proteins of haematophagous arthropods were
first studied for their allergenic properties. However,
there is strong evidence for their application in improv-
ing host protection against some vector-borne diseases
and for their use as alternative immunological tools to
assess individual exposure to haematophagous arthropod
bites. An overview of the pharmacological activity of the
main salivary proteins characterised in various haemato-
phagous arthropod species will first be presented to pro-
v i d eab e t t e ru n d e r s t a n d i n go ft h er o l eo fs a l i v ai nh o s t
defence, including haemostasis and the immune
response.
Blood-feeding behaviour among haematophagous
arthropods
The phylum Arthropoda represents the vast majority of
metazoan life forms on earth, with a species richness
estimated at 5-10 million [52]. The blood-feeding habit
has arisen and evolved independently in more than
14,000 species from 400 genera and five orders in the
arthropod taxonomy [1,53]. These independent adop-
tions of haematophagy during the evolution of arthro-
pod vectors required morphological, behavioural and
biochemical adaptations in order to remove blood from
the skin of vertebrate hosts. Indeed, blood is not an easy
access nutrient due to its cryptic nature in addition to
the host’s behavioural and biological defensive response.
Mouthparts have adapted the following two strategies
to obtain blood from vertebrates: (i) lacerating dermal
capillaries and collecting the nutritive fluid in a hemor-
rhagic pool (pool feeding or telmophagy, e.g., flies from
the families Tabanidae and Psychodidae and Ixodoidae
(ticks) and (ii) by directly inserting mouthparts into a
capillary (capillary feeding or solenophagy, e.g., Culicidae
Table 1 Taxonomic classification of major vector-borne
diseases
Vectors Diseases
Order Family Genius
Diptera Culicidae Anopheles Malaria,
Lymphatic filariasis
Culex West Nile disease
Japanese encephalitis
Aedes Yellow fever
Chikungunya
Dengue
Psychodidae Phlebotomus Leishmaniasis
Lutzomyia
Glossinidae Glossina Human African
Trypanosomiasis
Simulidae Simulium Onchocerciasis
Tabanidae Tabanus Loiasis
Hemiptera Reduviidae Triatoma Chagas disease
Rhodnius
Ixodida Ixodidae Amblyomma Rickettsiosis
Tularemia
Ixodes Lyme disease
Babesiosis
Haemaphysalis Tularemia
Tick borne encephalitis
Argasidae Ornithodoros Relapsing fever
The taxonomic classification of the major hematophagous arthropod vectors
described in the present review is given with their corresponding diseases.
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of these blood-feeding habits may have occurred in sev-
eral different ways. A prolonged and close association
between terrestrial hosts and arthropods that regularly
fed on dead parts of the host’s body or organic debris
associated with the nests or burrows may have gradually
established more profound parasitic relations charac-
terised by switching to a haematophagous diet. Alterna-
tively, the development of haematophagy would have
been facilitated in some capillary feeders by morphologi-
cal preadaptation of their ancestors to phytophagy or
entomophagy [2,54-56].
Other important blood-feeding behaviours are dis-
played among haematophagous arthropods, including
the duration of blood-feeding (which can range from
few minutes for Culicidae [57] to several days for ticks
[58]), the rate of anthropophily [59] or the obligate ver-
sus facultative haematophagous diet [56]. These singula-
rities among different haematophagous arthropods,
adding to other behavioural or biological features, such
as the length of the extrinsic incubation period (time
between the acquisition of an infectious agent by a vec-
tor and its ability to transmit it to other vertebrate
hosts) [60], the nycthemeral activity [61] or the repro-
ductive strategies (K- and r- selected arthropods) [62],
are additional features that may have significant implica-
tions on disease transmission and on the implementa-
tion of anti-vectorial strategies. However, whichever
blood-feeding strategies or feeding behaviour is used,
each adoption of haematophagy requires solutions to
counteract vertebrate host haemostatic, inflammatory
and immune responses. At the molecular level, haema-
tophagous arthropods have also developed, by an evolu-
tionary process, an important diversity of
pharmacological compounds in their saliva in order to
prevent these physiological responses.
The role of saliva in blood-feeding
Salivary components and host’s haemostasis
Haemostasis is a host cellular and molecular response
that prevents blood loss from a damaged vessel through
several redundant processes, such as blood vessel vaso-
constriction, formation of a primary platelet plug (pri-
mary haemostasis) or vessel strengthening by blood
coagulation (secondary haemostasis) [For review:
[63,64]].
Damage to blood vessel endothelium first results in
vasoconstriction that decreases blood flow at the bite
site to limit the haemorrhage. Two strategies are
employed by haematophagous arthropods to prevent
this phenomenon. Some arthropods display salivary
components which block host vasoconstrictor agents,
such as peroxidase from the Anopheles albimanus mos-
quitoes [65]. Other arthropods have strong vasodilators
in their saliva. For example, Lutzomyia longipalpis sand
flies and Simulium vittatum black flies express maxadi-
lan and Simulium vittatum erythema protein (SVEP) in
their saliva, respectively, which are the most potent
known vasodilators [66,67]. These two species are pool
feeders that require strong vasodilatory substances to
increase blood flow perfusion in superficial regions of
the skin. Closely related species can use separate
mechanisms to counteract vascular compression as illu-
strated by Phlebotomus sand flies that express adenosine
and 5’AMP vasodilators instead of maxadilan in their
saliva [68].
Vascular injuries due to the penetration of arthropod
mouthparts in the host skin are also accompanied by
the activation of platelets, which aggregate within sec-
onds to form a haemostatic plug using fibrinogen as a
connecting agent [63,69]. Convergent paths of evolution
have lead to similar molecules in different arthropod
species that inhibit or scavenge a panel of platelet-aggre-
gating factors (Additional file 1 Figure 1). Among them,
apyrase, an enzyme that hydrolyses ADP released by
damaged cells and activated platelets, is ubiquitously
found in the saliva of various haematophagous arthro-
pods [70-79]. Distinct salivary proteins from a single
species could present redundant effects, as illustrated by
the Rhodnius prolixus bug saliva, which contains both a
salivary apyrase and a protein named Rhodnius prolixus
aggregation inhibitor 1 (RPAI-1) that inhibits platelet
aggregation by direct binding to ADP [71,80]. More
diversified molecules targeting other platelet aggregation
agonists (e.g., thrombin, serotonin (5-HT) or thrombox-
ane A2) are exhibited by other arthropods (Additional
file 1 Figure 1).
This platelet activation prepares the implementation of
secondary haemostasis by exposing the surface of acti-
vated platelets to coagulation proteins. Through a series
of reactions involving several blood coagulation factors,
the coagulation pathway (including the contact activa-
tion pathway and tissue factor pathway) is propagated
until the formation of thrombin. The latter converts cir-
culating soluble fibrinogen into insoluble fibrin, leading
to blood clotting and complete cessation of haemor-
rhage [81-83]. As a result of convergent evolution, a
variety of unrelated arthropod species have developed
salivary inhibitors toward thrombin, a prime target to
overcome both primary and secondary haemostasis
(Additional file 1 Figure 1). As observed for primary
haemostasis, more than one anticoagulant compound
can be found in the saliva of a single haematophagous
arthropod, as exemplified by hamadarin and anophensin,
which are two anticoagulants targeting the contact acti-
vation pathway isolated in An.stephensi [84,85]. This
redundancy of function reinforces the efficiency of the
anti-haemostatic response.
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Adding to haemostatic defences, vertebrate hosts have
evolved systems of immune defences to eliminate for-
eign organisms in the body, which can largely impair
haematophagous arthropod blood-feeding. Tissue injury
causes the immediate onset of acute inflammation and
innate immunity, which promote tissue repair, prevent
colonisation of the damaged tissues by opportunistic
pathogens and initiates adaptive immunity, which is
more specific.
Inflammation is characterised by multiple interactions
between resident cells of the epidermis and dermis, such
as endothelial cells, leucocytes, mast cells, neutrophils
and platelets, which are the first to make contact with
arthropod mouthparts as well as their saliva and their
potential pathogens. These cells release pro-inflamma-
tory mediators and chemotactic factors such as hista-
mine, macrophage inflammatory protein-1a (MIP-1a)
and leukotrienes [86-88], which activate and recruit leu-
cocytes at the site of haemorrhage. The majority of sali-
vary molecules inhibiting or scavenging these pro-
inflammatory agonists were extensively studied in tick
saliva (e.g., argasid or ixodid) compared to other arthro-
pods (Additional file 1 Figure 2). Due to their habit of
remaining attached to their host for a long period to
feed until repletion, ticks are strongly dependent upon
the potent immunosuppressive activities of their salivary
components. Tick salivary components can then act on
different actors of the innate immune response, such as
the complement system [89-91], macrophages [92],
Figure 1 Schematic representation of arthropod salivary proteins acting on primary and secondary haemostasis. Haematophagous
arthropods (HA) induce injuries to vascular endothelium when probing for a blood meal. The initial event of this vascular damage is
vasoconstriction (1), which retards extravascular blood loss and enhances the adhesion of platelets to exposed subendothelial collagen. This
adhesion activates platelets (2) and causes the release of platelet activation agonists (Adenosine diphosphate (ADP), Thrombin, Thromboxane A2
(TXA2), serotonin (5-HT)) as well as platelet membrane integrin receptor aIIbb3. Fibrinogen binds to this receptor and crosslinks platelets to form
a platelet plug. The blood coagulation cascade (3) is then initiated to strengthen the platelet plug with fibrin at the site of injury. The
coagulation cascade is separated into two pathways converging into a common pathway. The contact activation pathway (intrinsic) involves
high-molecular weight kininogen (HMWK), prekallikrein (PK), factor XII, factor XI and factor IX (3a), and the tissue factor pathway (extrinsic)
involves the tissue factor and factor VII complex (3b). Both pathways lead to the activation of factor X. The common pathway leads to the
generation of thrombin from prothrombin and the ultimate production of insoluble fibrin from fibrinogen. HA have evolved anti-haemostatic
salivary proteins that inhibit specific agonists and factors of platelet aggregation and the blood coagulation cascade. The known actions of some
HA salivary proteins listed in Additional file 1 are indicated. (Salivary protein affiliation to HA families is indicated by colour as represented on the
bottom right corner legend).
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Page 4 of 17natural killer cells [93,94] and the synthesis of proin-
flammatory cytokines [95,96], to succeed their blood
meal. The suppressive effect induced by saliva on innate
immunity was less studied in other haematophagous
arthropods. Even though whole saliva or salivary gland
extracts from Culicidae and Psychodidae have been
found to induce a suppressive effect on innate immunity
[97,98], several immunosuppressor components remain
to be determined at the molecular level.
Tissue damage and inflammation can lead to the
extracellular production of adenosine from ATP degra-
dation. Adenosine can have analgesic or pronociceptive
effects depending on the activation of different periph-
eral receptors [99]. Pain perception can induce defensive
behaviours from the host that could be deleterious to
haematophagous arthropods. As a consequence, adeno-
sine deaminase enzymes detected in saliva of various
arthropods [100-102] were proposed to suppress pain
perception by degrading adenosine at the bite site [101].
The innate immune system can also influence the type
of adaptive immune response that develops. Haemato-
phagous arthropod saliva can greatly impair the develop-
ment of an appropriate adaptive immune response by
t h eh o s tb ya l t e r i n gt h ef u n c tion of antigen presenting
cells (APC), such as macrophages [103] or dendritic
cells (DC) [95,104,105]. These cells are involved in the
capture and processing of salivary or pathogen antigens
at the bite site, as well as in antigen presentation to T
lymphocytes in the draining lymph nodes [106], which
promotes cell and antibody mediated responses
Figure 2 Schematic representation of arthropod salivary proteins involved in the modulation of innate and adaptive immunity.
Protective immunity against haematophagous arthropods (HA) involves both innate and adaptive immunity. Cells involved in the innate
response (e.g., neutrophils, natural killers cells (NK), mast cells and macrophages (MF)) represent the first line of defence. Once activated, these
cells release molecules (e.g., macrophage inflammatory proteins -1 a (MIP-1a), tumour necrosis factor- a (TNF- a) or leukotrienes (LB4, LTC4) that
initiate the inflammation process. This local inflammation can further be triggered by the activation of complement, which has chemotactic and
inflammatory properties. Endothelial cells and platelets can be activated by the binding of factors of the coagulation cascade to PAR receptors,
leading to an over-expression of surface adhesive molecules (ICAMs, E-selectin, P-selectin) that participate in neutrophil migration. Antigen
presenting cells, such as dendritic cells (DC) migrate to the lymph nodes where they interact with naïve CD4+ helper T lymphocytes (Th0 cells)
via the interplay of their T cell receptors (TCR) and major histocompatibility complex (MHC) class II proteins. Th0 cells have the potential to
proliferate and to differentiate into two distinct lineages of effectors cells: Th1 and Th2 cells. Memory T helper (Th M) cells, which can improve
the quality of the response to a subsequent exposure by developing more efficient memory capacity over time, are also produced. In a general
pattern, HA saliva down-regulates the expression of Th1 cytokines (such as IL-2) modulating the adaptive immune response to an antibody
mediated Th2 response. The action of saliva or salivary proteins is indicated in the figure as well as their corresponding organism’s family.
(Salivary protein affiliation to HA families is indicated by colour as represented on the bottom right corner legend).
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Page 5 of 17[107,108]. As a generalized pattern, salivary gland
extracts from several haematophagous arthropods can
inhibit Th1 cytokines secretion, such as IFN-g and IL-2
[109-112], promoting the development of an antibody-
mediated Th2 response [113-117]. This polarisation of
host immunity toward a Th2 response (to the detriment
of a Th1 cell-mediated response) is beneficial to the suc-
cess of the blood feeding but it may also have a benefi-
cial impact on pathogen transmission.
Salivary components and enhancement of vector-borne
pathogens infection
The discovery of the immuno-modulatory property of
saliva has stimulated several research groups to study
the involvement of salivary proteins from diverse vectors
in the transmission and the establishment of corre-
sponding pathogens into their hosts.
Titus and Ribeiro were the first to describe the enhan-
cing effect of sand fly salivary gland extracts on cuta-
neous leishmaniasis when coinoculated with Leishmania
promastigotes. Mice injected with Leishmania parasites
concomitantly with a small amount of salivary gland
proteins developed larger lesions and harboured more
parasites than controls [118]. The enhancing effect of
salivary extracts was confirmed with other Leishmania
and sand fly species [119,120]. Subsequent studies have
demonstrated that the injection of Triatominae bug sal-
iva into the skin of mice in the presence of Trypano-
soma cruzi parasites induced an up to six-fold blood
parasitaemia [121], and that the saliva of ixodid ticks
potentiated the transmission of Thogoto virus [122].
Interestingly, enhancement of Thogoto virus infection
was only observed with salivary gland extracts derived
from metastriate ixodid ticks but not from prostriate
ixodid ticks, argasid ticks or mosquito saliva [122].
These results highlight the strong specificity of the vec-
tor/pathogen interaction that is needed in order to
potentiate this enhancing transmission effect and sug-
gest that this effect may involve a limited number of
specific proteins to the haematophagous arthropod spe-
cies or genus.
Effectively, in Lutzomyia longipalpis sand fly, the vaso-
dilator maxadilan appears as the principal salivary mole-
cule responsible for this enhanced parasite transmission
as it exacerbates infection with Leishmania major to the
same degree as whole saliva [123]. For Borrelia burgdor-
feri, the spirochetal agent of Lyme disease, the Salp15
protein expressed in Ixodes scapularis tick saliva
enhances its transmission and survival within the verte-
brate host. The spirochaete pathogen specifically up-reg-
ulates the expression of Salp15 and associates with it in
order to be protected from borreliacidal effects induced
by antibody-mediated killing [124]. The enhanced infec-
tion induced by saliva seems to be a widespread
phenomenon in various vector species and for various
viruses, bacterial or parasite pathogens [121,122,125,126].
Mosquito saliva might also accelerate and amplify infec-
tions of West Nile virus [127,128], La Crosse virus [129]
or Cache-valley virus [130]. All these data suggest that
haematophagous arthropod vectors are not simply “flying
or crawling” s y r i n g e sb u tr a t h e rp l a yad y n a m i cr o l ei n
the host/vector/pathogen relationship. The participation
of saliva components in this transmission is supported by
the increase infectivity observed when pathogens are
delivered to the host by haematophagous arthropod bites
compared to delivery by a syringe without saliva proteins
[129,131-133].
All salivary proteins characterized in various hemato-
phagous arthropods so far give a global overview of
their complexity as well as their diversity both at their
molecular level as well as their targets. It is interesting
to note that only a minority of these salivary proteins
has been assigned a precise function. For instance, con-
cerning any tick species with a known genome or sali-
vary gland transcriptome, less than 5% of the salivary
proteins have their function verified [5]. Further knowl-
edge on the pharmacology of arthropod salivary proteins
might thus lead to the discovery of novel vasodilator,
anti-platelet, anti-clotting, analgesic or immunomodula-
tory compounds, used by hematophagous arthropods to
counteract host defenses. In addition, these salivary
molecules might also provide new immunological tools
to combat the direct and indirect nuisance caused by
these hematophagous arthopods.
Salivary proteins and host antibody response:
immunological tools in sight?
Saliva of haematophagous arthropods and allergy
Since the mid-1930s, numerous studies have described
host immediate-type hypersensitivity (ITH) reactions in
response to the bite of various haematophagous arthro-
pod families, such as Psychodidae [134], Culicidae
[135-137] or Glossinidae [138]. This ITH skin reaction,
also known as type I hypersensitivity, is now widely
accepted to be an allergic reaction which involves the
production of IgE antibodies in response to specific sali-
vary allergens [6]. Several studies have attempted to
characterise the allergens involved in ITH by using dif-
ferent techniques (e.g.,s k i nt e s t i n g ,R A S T ,E L I S A ,
Immunoblot) and different allergen preparations with
the aim of developing tools for diagnosis and treatment
of allergic reactions [139,140]. The comparison of the
allergenic potency of whole body, thoracic and abdom-
inal hemolymph and salivary glands from Triatoma pro-
tracta (reduviid bug) by RAST inhibition demonstrated
that the allergens were concentrated in the salivary
glands [139]. Similar results were observed for the
Ixodes holocyclus tick [141]. Recently, Wongkamchai
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allergens are more abundant in saliva, followed by sali-
vary gland extracts and whole body extracts from four
mosquito species [142]. These different studies con-
firmed that the more concentrated source of allergens is
located in saliva and salivary glands from haematopha-
gous arthropods. Thus, saliva appears to be the prime
antigenic source for testing or treating haematophagous
arthropod-induced allergic reactions [143].
However, the collection of saliva is tedious, time con-
suming and constitutes a major drawback to the wide-
spread medicinal use of these salivary components
[143]. Hence, the synthetic production of arthropod vec-
tor saliva allergens is a promising alternative strategy for
producing safe and highly standardized allergens on a
large scale. A panel of studies using the immunoblot
method have revealed a number of salivary proteins
detected by IgE antibodies of individuals with skin
hypersensitivity to arthropod bites, including mosquitoes
[140,144-148], ticks [141,149] or reduviid bugs
[139,150]. Some of these salivary allergens are now well
characterised. For example, three recombinant Aedes
aegypti salivary allergens corresponding to a 68 kDa sali-
vary apyrase (rAed a1), a 37-kDa protein belonging to
the D7 family (rAed a2) and a 30 kDa salivary gland
allergen (rAed a3) elicit predominantly IgE responses in
mosquito-allergic individuals [151,152]. The authors
concluded that these recombinant allergens could
greatly facilitate the diagnosis and immunotherapy of
mosquito allergies. Recombinant salivary allergens were
also evaluated in other haematophagous arthropod spe-
cies and are presented in Table 2.
Currently, whole body extracts from mosquitoes are
used in the diagnosis and immunotherapy of mosquito
bite allergies [153,154]. However, these commercially
available samples contain many extraneous proteins that
are not present in mosquito saliva and might interfere
with diagnostics or may even cause additional sensitisa-
tion in subjects with a history of allergic reactions to
mosquito bites. Moreover, the treatment of mosquito
allergies is not widely used because considerable varia-
tions in the biological activity of these mosquito whole
body allergen extracts have been described [155]. Thus,
synthetic allergens appear to be a promising alternative
for the diagnosis of allergic individuals, but also may
improve desensitisation protocols and overcome the lack
of standardisations in allergen immunotherapy [7,142].
Saliva of haematophagous arthropods and vaccines
Over the course of the past 20 years, it has been
observed that a history of exposure to uninfected bites
has the ability to protect against several vector-borne
infections, including tularaemia [156] and Lyme borre-
liosis [157] in animals pre-exposed to tick bites. The
hypothesis that salivary components could be effective
vaccine candidates for reducing the morbidity of vector-
borne diseases in exposed individuals was strengthened
by the discovery that pre-exposure of mice to salivary
Table 2 Recombinant salivary proteins characterized in hematophagous arthropods and their immunological
applications
Protein
names
Organisms Additional informations MW
[kDa]
Application Ref.
rAed a1 Aedes aegypti Salivary apyrase 68 Allergy [151,152]
rAed a2 Aedes aegypti Belong to the D7 family 37 Allergy [151,152]
rAed a3 Aedes aegypti 30 kDa salivary gland allergen 30 Allergy [151,152]
Procalin Triatoma protracta Belong to the lipocalin family 20 Allergy [225]
Arg r 1 Argas reflexus Belong to the lipocalin family 17 Allergy [227]
Der-p2 Ixodes ricinus Dermatophagoides pteronyssinus allergen-
like
15.6 Allergy [226]
TAg5 Glosina m. morsitans Tsetse Antigen 5 28.9 Allergy [228]
Maxadilan Lutzomyia longipalpis - 9.5 Vaccine candidate [123]
SP15 Phlebotomus papatasi - 15 Vaccine candidate [162]
rLJM19 Lutzomyia longipalpis - 11 Vaccine candidate [229]
Salp15 Ixodes scapularis - 14.7 Vaccine candidate [163]
gSG6 Anopheles gambiae - 10 Immunological marker of
exposure
[218,219,230,220]
rTC Amblyomma.
americanum
Calreticulin 47.5 Immunological marker of
exposure
[221]
rLJM11 Lutzomyia longipalpis Yellow-related protein 43 Immunological marker of
exposure
[223,224]
rLJM17 Lutzomyia longipalpis Yellow-related protein 45 Immunological marker of
exposure
[223,224]
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size of dermal lesions and reduces Leishmania major
parasite loads in tissue [158]. More recently, it was
shown that pre-exposing mice to Anopheles stephensi
bites could protect them from rodent malaria [159], but
these results are controversial [160].
These protective effects might be partly due to the
development of host immunity against vector salivary
proteins described as enhancing pathogen establishment.
Based on these reflections, Morris and colleagues have
tested the potential of Lutzomia longipalpis maxadilan
as a vaccine candidate to protect mice against Leishma-
nia infection (Table 2) [123]. Mice vaccinated with syn-
thetic maxadilan were highly resistant to infection, as
evidenced by smaller cutaneous lesions and a shorter
healing period compared to controls. As maxadilan is
only expressed in New World Psychodidae from the
genus Lutzomia [68], it cannot confer protection against
Leishmania infection transmitted by Old World sand
flies from the genus Phlebotomus. However, vaccination
with SP15, a 15 kD salivary protein from the Old World
P. papatasi sand fly, protected mice from Leishmania
infection [161,162]. These results highlight the challenge
in developing a universal vaccine to control a specific
pathogen transmitted by several vector species. Indeed,
the variability in the salivary repertoire of closely related
vector species implies that one must develop a salivary
vaccine candidate for each different vector transmitting
a specific pathogen. Additionally, one must take into
account the geographical distribution of these vectors to
determine the appropriate candidates that should be
used during vaccination campains.
The efficacy of the Salp15 salivary protein as a vaccine
candidate, the other well described salivary molecule
isolated in I. scapularis ticks with an enhancing effect
on pathogen transmission, was also tested in vivo.M i c e
immunised with recombinant Salp15 proteins were par-
tially protected against Lyme borreliosis spirochetes
transmitted by I. scapularis ticks [163]. Interestingly, the
co-immunisation with Salp15 and OspA (a Borrelia
burgdorferi outer-surface protein [164]) exerts a better
protection against B. burgdorferi than either of these
two candidates when used alone. Thus, the conjunction
of salivary proteins to traditional pathogen-based vac-
cine could improve host protection against vector-borne
disease infection. To our knowledge, no vaccine candi-
dates have been developed against salivary components
from other haematophagous arthropods. This relatively
new vaccine approach (i.e., targeting arthropod salivary
components required by a pathogen for its establish-
ment in the host) necessitates the characterisation of
salivary components exhibiting an enhancing effect on
pathogen infection. The development of multi-epitope
vaccines by the combination of pathogen-derived
antigens with appropriate salivary antigens from their
corresponding vectors could provide a better protection
against vector-borne diseases than pathogen-derived
vaccine candidates alone. Recently, An. stephensi saliva
was reported to enhance the progression of cerebral
malaria in a murine model [165]. The further characteri-
sation of salivary components involved in this effect
might lead to potential vaccine candidates, which could
be used in combination with other malaria vaccine can-
didates to protect against severe malaria [166,167].
Other vaccine strategies using salivary proteins were
undertaken in order to reduce host/vector contact by
avoiding blood intake or diminishing the duration of the
blood meal, particularly in ticks [168-170]. Additionally,
vaccine candidates targeting gut or body haematopha-
gous arthropod antigens were also developed to either
disrupt the biology of the vectors or to block pathogen
transmission. These approaches are promising to control
vector-borne diseases but are beyond the scope of this
review; supplementary details can be found in other
works [171-175].
Saliva of haematophagous arthropods and exposure
markers
Relationship between anti-saliva IgG responses and
haematophagous arthropod exposure
The absence of an antibody response against saliva from
mosquitoes or Culicoides midges in the sera of children
[176] or horses [177] living in Iceland (a country exempt
from these two biting arthropods) and the appearance of
an IgG antibody responses in animals or humans follow-
ing exposure to haematophagous arthropod bites
[144,177-179] are strong arguments suggesting that the
acquisition of an antibody response against haematopha-
gous arthropod saliva is exposure dependent.
The correlation between arthropod exposure and the
level of anti-saliva IgG antibody was first evidenced
using the sera from outdoor workers (in New Jersey, U.
S.A.) who had been exposed to Ixodes damini ticks dur-
ing their forestry activities [180]. Moreover, a significant
decrease of the IgG anti-tick saliva levels was observed
in the absence of tick exposure for several months
( f r o mO c t o b e rt oJ a n u a r y )[ 1 8 0 ] .F r o mt h i sp o i n t ,s e v -
eral serological analyses demonstrated a relation
between the density of diverse haematophagous arthro-
pods and the level of antibody responses against their
saliva. A kinetic analysis oft h es e r o l o g i c a lr e s p o n s e
against Aedes communis saliva from individuals living in
Finnish Lapland indicated that seasonal exposure to
mosquito bites elicited more intense antibody responses
toward salivary antigens [181]. In a larger cohort, using
sera from 1,059 Canadian blood donors sampled before
and after the summer mosquito exposure peak, Peng
and colleagues showed significant higher level of IgG
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peak exposure [182]. Higher levels of anti-saliva IgG
antibodies were also detected in individuals exposed to
Glossina bites compared to non-exposed individuals
[50]. These works demonstrated that levels of serological
immune responses could be influenced by seasonal var-
iations of the level of haematophagous arthropod
densities.
Additionally, Orlandi-Pradines and colleagues have
evaluated the consequences of a transient exposure to
An. gambiae and Ae. aegypti mosquitoes in French tra-
vellers during a five-month journey to tropical Africa on
anti-saliva IgG responses [49]. This study reported that
several travellers from areas free of An. gambiae and Ae.
aegypti mosquitoes developed an antibody response
against saliva from these two unrelated mosquitoes.
Thus, transient exposure (e.g., seasons or travel into
endemic areas) to haematophagous arthropod bites
seems sufficient for developing an IgG response against
arthropod saliva. Additionally, IgM antibodies directed
against Triatoma infestans saliva can be detectable as
e a r l ya so n ed a ya f t e ras i n g l ee n c o u n t e rw i t hs e v e r a l
triatomine bugs and decrease even more rapidly (18
days) than IgG in chickens [183]. These IgM responses
seem highly sensitive to the detection of bug exposures;
however, no association was observed between level of
exposure and IgM antibody levels. These results high-
light the potential use of the short persistence of IgM
responses (as a complement to measuring IgG
responses) as an indicator of recent exposure to haema-
tophagous arthropods. The observed link between anti-
saliva antibody responses and haematophagous arthro-
pod exposure, as well as the waning of these antibody
responses after a period of non-exposure, favour the
potential use of immunogenic saliva as an immunologi-
cal marker of exposure. Indeed, simple blood sampling
would give an indication of individual exposure to the
bites of specific vectors and could be used to complete
entomological surveys or to replace them when human
landing catch or other trapping methods are difficult to
implement [184]. Saliva-based immunological markers
of exposures would also be more appropriate than mea-
suring vector-borne disease incidence in clinical trials to
assess the effectiveness of anti-vectorial devices in areas
with low pathogen transmission intensity [185]. Finally,
it could be an alternative strategy compared to entomo-
logical methods (i.e., human landing catch) to assess
vector bite exposure particularly in children [186].
In a recent clinical assay, Drame and colleagues con-
firmed the validity of using An. gambiae c r u d es a l i v aa s
an immunological marker to assess the efficaccy of
insecticide-treated nets (ITNs) in a malaria hypo-ende-
mic transmission area [187]. They measured anti-saliva
IgG levels, blood parasitaemia and vector densities
before and after the introduction of ITNs. A significant
decrease in the anti-saliva IgG response was observed
after the introduction of ITNs. This diminution of anti-
body response was associated with a drop in parasite
load but not with vector densities as measured by light
traps, a standard but highly biased and imprecise ento-
mological methods. Recently, antibody responses from
sentinel guinea pigs to salivary proteins of T. infestans,
the vector of T. cruzi, was shown to be a powerful tool
for the evaluation of vector control interventions against
Chagas disease [188]. These studies demonstrated that
anti-saliva antibody responses could be efficient tools to
assess the effectiveness of antivectorial strategies imple-
mented to control diverse vector borne diseases by giv-
ing an estimation of the real intensity of
haematophagous arthropod bites at the individual level.
Thus, variations of the IgG antibody level appeared to
be correlated with haematophagous arthropod density,
which was dependent on several factors, such as sea-
sons, ecological environments, individual activities or
the level of anti-vectorial protection.
Diversity and specificity of salivary components
As some areas can exhibit a high biodiversity in terms
of haematophagous arthropod species [189,190], a high
level of specificity is necessary to assess individual expo-
sure by immunological tests based on haematophagous
arthropod saliva. Several studies have reported diverse
degrees of cross-reactivity between different vector spe-
cies, ranging from low [191,192] to high species-specifi-
city [150,193-195]. The presence of cross-reactivity was
often described in related species [191,192], suggesting
that this phenomenon can occur in closely related saliva
components.
The specificity of the saliva based immunological test
is a prerequisite to assess individual exposure to a speci-
fic genus or species of arthropods. An important step
forward in the knowledge of the salivary protein diver-
sity in the phylum Arthropoda was the cataloguing of
salivary gland proteins expressed and secreted in several
species of haematophagous arthropods. The recent elu-
cidation of the genome of major haematophagous
arthropods [196-200] added to increasing transcriptomic
and proteomic work on salivary glands, making it possi-
ble to identify salivary molecules in various haematopha-
gous arthropods. To date, the transcription repertoire
(named sialotranscriptome) of at least 30 different spe-
cies of haematophagous arthropods has been drawn up,
revealing a number of both ubiquitous and specific pro-
teins throughout the taxonomic hierarchy [201-208].
The independent evolution of haematophagous arthro-
pods and host immune pressure over the salivary pro-
ducts led to a diversity of pharmacological molecules
even among different genera within a same family
[205,209]. An insight into the taxonomic variability at
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arthropod salivary proteins is shown on Figure 3. The
homology/diversity of salivary proteins can be observed
at two levels: (i) Homologous salivary proteins can be
conserved at different taxonomic levels from genus to
the entire arthropod phylum and (ii) the distribution of
percentage identity of homologous proteins inside each
taxonomic level is highly variable. This supports the
existence of numerous candidates that can be used to
assess individual exposure to specific haematophagous
arthropods.
Interestingly, studies on haematophagous arthropod
saliva generally use inbred laboratory strains. However,
for one species, there exist distinct colonies coming
from arthropods collected in the field that differed in
their origins and laboratory colonisation histories. In
order to evaluate sialome divergence, which could occur
following the rearing of haematophagous arthropods
over several decades (e.g., mosquitoes), under laboratory
conditions, the sialomes (i.e., saliva and salivary gland)
of three mosquito colonies (i.e., Ae. aegypti colonies
Rockefeller, PAEA and Formosus)w e r ec o m p a r e du s i n g
1D SDS-PAGE [143,210]. At t h es a l i v aa n ds a l i v a r y
gland level, no major differences were detected between
these three colonies, suggesting that the expression of
salivary proteins is highly conserved across populations.
Figure 3 Protein sequence diversity of haematophagous arthropods salivary proteins. Sequences of 13 salivary proteins of
haematophagous arthropods described in the present review were submitted to BLAST analysis on the non-redundant protein database (NCBInr,
NIH, Bethesda). The blastp program was used with default parameters excepting the following: search was done on the Arthropoda taxonomic
level (taxid: 6656, Nov 15
th, 2010, 12,289,957 sequences), the E-value threshold was changed to a setting of 1 in order to recover only hits with
highest significance on the overall protein sequence and the hit-list size was set to 5000 proteins. The number of homologous proteins with a
score above 40 and their respective percentage of coverage and identity were recovered for all query proteins and sorted according to their
increasing percentage of coverage. The number of homologous proteins is indicated in brackets (this includes the query sequence) and the
distributions of both the percentage of coverage (bar graph with a coloured scale) and the percentage of identity (line profile above each bar
graph) are represented. Proteins are grouped according to the taxonomic level of the last common taxon regrouping their corresponding
homologous proteins. For graphical convenience, subclass, class and infraclass as well as superfamily, family and subfamily taxonomic levels were
grouped into class and family, respectively. Salivary proteins reported to be targeted by an immune response are indicated by an asterisk (*).
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long history of laboratory rearing might have induced a
homogenisation of salivary protein repertoires, which
may differ from their field counterparts. This loss of
salivary protein diversity as a result of long-term coloni-
zation was hypothetised to be responsible of the
observed positive effects on the outcome of Leishmania
infection on mice pre-immunized with sand fly saliva
[211]. Indeed, pre-immunization of mice with saliva
from long-term colonized phlebotomine sand flies, was
reported to induce a better protection against Leishma-
nia infection than saliva from wild-caught or recently
colonised sand flies [211,212]. This preserved repertoire
of salivary proteins at the species level is essential to
develop anti-saliva based immunological tools to assess
individual exposure to different haematophagous arthro-
pod colonies settled in various areas throughout the
world. The access of salivary samples from wild-caught
arthropods using convenient procedures adapted to field
works would allow to assess the sialome diversity
between laboratory reared and wild arthropods [213].
Synthetic salivary components as immunological markers of
exposure
Major limits for developing a biological test of exposure
to haematophagous arthropod bites are the difficulty of
collecting saliva or salivary gland extracts and the lack
of standardisation in sampling. Effectively, the salivary
protein content of haematophagous arthropods can vary
according to their sex, age or diets [214-216]. Thus, a
gain of sensitivity, specificity and reproducibility could
be obtained by identifying the genus or species-specific
immunogenic salivary proteins and to produce them in
recombinant form or synthetic peptides.
The recombinant Anopheles gambiae salivary gland
protein 6 (gSG6), a small salivary protein highly pre-
served in the Anopheles genus [217], was evaluated as
an immunological marker of exposure [218]. The
recombinant protein was detected by IgG antibodies
from children exposed to the bite of An. gambiae.
B L A S Ta n a l y s i s( N C B I n r ,N I H ,B e t h e s d a ,N o v1 5 t h ,
2010) revealed that homologous proteins of gSG6
protein can only be found in 8 Anopheles species so
far, suggesting its specificity to the Anopheles genus
(Figure 3). This protein has recently been proposed as
a serological candidate marker of exposure to Afro-
tropical malaria vectors [219,220]. Human hosts
exposed to Amblyomma americanum and Dermacen-
tor variabilis ticks also develop a specific IgG
response against a recombinant calreticulin (rTC)
protein isolated from the salivary glands of the A.
americanum tick [221]. The use of recombinant sali-
vary proteins, which are highly preserved between
several related vector species, could be useful in
assessing the risk of disease transmission in
individuals living in areas where vector diversities are
not well characterised at the species level. Interest-
ingly, anti-rTC antibody seropositivity has higher spe-
cificity but lower sensitivity than antibodies directed
against whole saliva in detecting individuals that have
been exposed to ticks [222]. The use of a single
recombinant salivary protein to assess individual
exposure to tick bites may explain this lack of sensi-
tivity. Indeed, the use of two recombinant proteins
(named LJM17 and LJM11) was reported to be more
effective and sensitive than whole saliva to estimate
the level of exposure to Lutzomia longipalpis sand
flies, vectors of Leishmania parasites [223,224].
Recombinant proteins that have been primarily pro-
duced for their biological properties or their role in
allergic responses (Table 2) could also be considered
potential markers of exposure candidates [225-229].
Some of these proteins appear to be relatively specific to
the vector family or genus (Figure 3) and might be pro-
mising epidemiological markers of vector exposure.
Ribeiro and colleagues classified conserved salivary pro-
teins at different taxonomic levels in the suborder
Nematocera from which some other specific antigenic
candidates might emerge [205].
The detection and selection of highly specific peptides
inside the whole salivary protein sequence could further
increase the specificity of such immunological markers
and reduce production costs. In order to optimise the
specificity of the gSG6 biomarker, Poinsignon and col-
leagues have designed a gSG6-based peptide sequence
(gSG6-P1) according to its predicted immunogenic
properties [218]. A positive association between the
anti-gSG6-P1 IgG responses and the level of exposure
was observed in individuals exposed to An. gambiae
bites. This peptide was also detected in individuals
exposed to a very low number of the malaria vector
bites, suggesting its potential to reveal An. gambiae
exposure in a context where classical entomological
methods would be employed with difficulty (i.e.,u r b a n
areas, altitude, travellers) [230].
Taken together, all these data support the use of
immunogenic salivary components as new tools for
identifying individuals at risk to vector-borne diseases
and for monitoring haematophagous arthropod popula-
tions and anti-vector intervention strategies. A gain of
sensitivity and specificity could be achieved by the selec-
tion and production of recombinant antigens or peptides
that do not share sequence homology with other haema-
tophagous arthropod species. Such synthetic products
increase the amount of available protein for large cohort
studies using high-throughput methods such as Lumi-
nex technology. These multiplex assays are cost and
time effective and have proven to be useful strategies for
the detection of serum antibodies directed against
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dual exposure to vector borne diseases [233].
Conclusion
In order to facilitate their blood meals, haematophagous
arthropods have elaborated a wide range of salivary
components that have essential roles in counteracting
host haemostatic defences. In addition to these pharma-
cological activities, salivary components can modulate
host immunity at the bite site and induce an immune
environment favourable for pathogen transmission. This
immuno-modulation is associated with the production
of specific antibody responses. Since the 1980s, several
studies have investigated the antibody responses of ver-
tebrate hosts against salivary proteins in an initial
attempt to treat uncomfortable allergic reactions to hae-
matophagous arthropod bites. The immunogenic prop-
erties of some salivary proteins can be used as vaccine
candidates for improving host protection against some
vector-borne diseases. Salivary proteins are likely to
become immunological markers for relevant estimation
of vector/host contacts, of the effectiveness of various
control or surveillance programs, and an estimation of
the pathogen transmission risk to complement methods
that are currently available. A gain in sensitivity, specifi-
city and reproducibility is expected to be obtained by
the identification of species-specific immunogenic sali-
vary peptides or the combination of several recombinant
salivary proteins.
Additional material
Additional file 1: Anti-hemostatic and immunomodulatory salivary
proteins in hematophagous arthropods. Known anti-hemostatic and
immunomodulatory properties of salivary proteins from diverse
hematophagous arthropods are presented.
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